Lite Strategy (LTS:0JW9) Other Current Receivables: $0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0JW9 Lite Strategy Inc LTS:0JW9
44 GF Score
Price $0.93
GF Value $6.98
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Lite Strategy Other Current Receivables?

Lite Strategy LTS:0JW9 -4.22% 44 Other Current Receivables is $0.00 Mil as of Mar. 2026. GuruFocus rates LTS:0JW9 with a GF Score™ of 44/100 and a GF Value™ of $6.98 (Possible Value Trap). The stock has 2 warning signs investors should review.

Lite Strategy's Other Current Receivables for the quarter that ended in Mar. 2026 was $0.00 Mil.

Lite Strategy's annual Other Current Receivables declined from Jun. 2023 ($0.09 Mil) to Jun. 2024 ($0.00 Mil) but then stayed the same from Jun. 2024 ($0.00 Mil) to Jun. 2025 ($0.00 Mil).

Lite Strategy Other Current Receivables Related Terms

Lite Strategy Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Lite Strategy's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lite Strategy Other Current Receivables Chart

Lite Strategy Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.58 10.04 0.09 0.00 0.00

Lite Strategy Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0JW9
44GF Score
Lite Strategy Inc LTS:0JW9
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lite Strategy Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.00 Mil mean?
Lite Strategy (LTS:0JW9) has a Other Current Receivables of $0.00 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Lite Strategy and its competitors.
Is Lite Strategy's Other Current Receivables too high?
Lite Strategy's current Other Current Receivables is $0.00 Mil. Overall, Lite Strategy has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lite Strategy's Other Current Receivables compare to ESLA and NNVC?
Lite Strategy's Other Current Receivables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Lite Strategy and its competitors. Lite Strategy's current Other Current Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lite Strategy stock overvalued right now?
Based on GuruFocus' analysis, Lite Strategy (LTS:0JW9) is currently considered Possible Value Trap. The stock's GF Value™ is $6.98, compared to a current price of $0.93 — trading 86.7% below its estimated fair value. The current Other Current Receivables is $0.00 Mil. Lite Strategy's overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Lite Strategy (LTS:0JW9), the current Other Current Receivables is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lite Strategy (LTS:0JW9) Overvalued in 2026?

Based on GuruFocus' analysis, Lite Strategy stock appears to be undervalued. The current stock price of $0.93 is trading 86.7% below its estimated GF Value™ of $6.98. GuruFocus considers Lite Strategy to be Possible Value Trap.

Key valuation signals for LTS:0JW9:

  • Other Current Receivables: $0.00 Mil
  • GF Value™: $6.98 vs. price of $0.93 (86.7% below fair value)
  • GF Score™: 44/100 with 2 warning signs

No single metric tells the full story. See the LTS:0JW9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lite Strategy Business Description

Other Exchanges LITS:USA
Address 9920 Pacific Heights Boulevard, Suite 150, San Diego, CA, USA, 92121
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
44GF Score

Get the complete analysis for LTS:0JW9

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.93
Price
$6.98
GF Value